Today, I’m delighted to be launching the Regionalized Vaccine Manufacturing Collaborative’s – RVMC - strategy for the next three years.

RVMC was founded in 2022 with a collective mission to improve vaccine equity and health security around the world through the establishment of regional vaccine manufacturing and supply chain networks. So far in 2024 we have created a full-time Secretariat hosted by CEPI, and published a comprehensive Framework Report on what it will take to realise our mission.

We’re launching this strategy at a time of considerable interest and activity around regional vaccine manufacturing. Spurred on by the deep inequities in vaccine access experienced during the COVID-19 pandemic, the past two years has seen a surge in public and private investments in regionalized vaccine manufacturing.